LENZ Therapeutics, Inc.LENZ

$6.15-0.19 (-3.00%)

NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap

$193M

Micro-cap

-68%

2021 — today

10-Year Price

-92%

2021 — today

52-Week Range

$6.15$49.05

Current $6.15· 0%

LENZ Therapeutics, Inc. is a biopharmaceutical firm whose primary mission involves the advancement and commercialization of new treatments designed to enhance vision for individuals in the United States. The company's portfolio features two investigational products, LNZ100 and LNZ101, both of which are currently undergoing late-stage Phase III clinical trials as potential solutions for presbyopia. Corporate operations for LENZ Therapeutics are situated in Del Mar, California.

Valuation in context

P/E ratio

-1.7

N/A

Not meaningful — company is unprofitable

P/B ratio

0.8

Around average

Around the 10-year average

FCF Yield

-45.4%

Below average

Below the 10-year average

Free · No credit card needed

Get alerted when LENZ is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.